Novel Technique for Fluorescence Tomography of Tumors in Living Animals

Fluorescent molecules - i.e. substances which can be stimulated to emit light - are extremely valuable tools in biological research and medical diagnosis. Fluorescence can be used for instance to analyze the regulation and expression of genes, to locate proteins in cells and tissues, to follow metabolic pathways and to study the location and migration of cells. Of particular importance is the combination of fluorescence imaging with novel techniques that allow tomographic three-dimensional visualization of objects in living organisms.

At the Helmholtz Zentrum München - German Research Center for Environmental Health together with the Technische Universität München an own institute is concerned with the development and refinement of such new technologies: the Institute for Biological and Medical Imaging headed by Professor Vasilis Ntziachristos.

The quality of optical imaging in tissues is naturally limited, since beyond a penetration depth of a few hundred micrometers the photons are massively scattered due to interactions with cell membranes and organelles which results in blurred images. In the latest issue of the journal Proceedings of the National Academy of Sciences Prof. Ntziachristos and his team, together with colleagues from the Harvard Medical School and the Massachusetts General Hospital in Boston, USA, report on the use of the so-called early arriving photons together with tomographic principles. Early photons are the first photons that arrive onto a photon detector after illumination of tissue by an ultra-short photon pulse and undergo less scattering in comparison to photons arriving at later times. Compared to continuous illumination measurements a combination of these less scattered photons with 360-degree illumination-detection resulted in sharper and more accurate images of mice under investigation.

With this technique, called 'Early Photon Tomography' (EPT), the scientists imaged lung tumors in living mice. For this purpose they injected a substance into to the animals, which normally does not fluoresce, but becomes fluorescent after contact with certain cysteine proteases such as cathepsins. The amount of these proteases is enriched in lung tumors which allows fluorescence imaging of the tumor tissue. Comparison with conventional x-ray tomography showed, that EPT is not only a very sensitive technique for imaging of lung tumors in living organisms, but also has the potential to reveal biochemical changes that reflect the progression of the disease, which could not be detected by conventional X-ray imaging.

While early-photons are typically associated with reduced signal available for image formation, the authors demonstrated that due to the wide-field implementation, EPT operates with very small reduction in average signal strength as in conventional tomographic methods operating using continuous light illumination. In this respect EPT is a practical method for significantly improving the performance of fluorescence tomography in animals over existing implementations. At present EPT is practicable only with small animals, but - as stated by the authors of the paper - further development of the equipment can allow niche applications of the technique also with larger organisms including humans.

Publication:
Niedre, M.J., de Kleine, R.H., Aikawa, E., Kirsch, D.G., Weissleder, R., Ntziachristos, V. (2008): Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proceedings of the National Academy of Sciences; Published online before print November 17, 2008, doi: 10.1073/pnas.0804798105

For further information, please visit:
http://www.helmholtz-muenchen.de/en/ibmi/

About Helmholtz Zentrum München
The Helmholtz Zentrum München is a research institution of the Federal Government and the State of Bavaria within the Helmholtz Association of German Research Centres, the largest scientific organisation in Germany.

The Helmholtz Association is a community of 15 scientific-technical and biological-medical research centres. These centres have been commissioned with pursuing long-term research goals on behalf of the state and society. The Association strives to gain insights and knowledge so that it can help to preserve and improve the foundations of human life. It does this by identifying and working on the grand challenges faced by society, science and industry. Helmholtz Centres perform top-class research in strategic programmes in six core fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter, Transport and Space.

In future, the Helmholtz Zentrum München will be represented within the research field Health of the Helmholtz Association with both programs, Environmental Health und Systemic Analysis of Multifactorial Diseases, as well as in the field Earth and Environment with the Terrestrial Environment program.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...